Botswana Explores Pharmaceutical Production Through Cyprus Collaboration

Botswana Explores Pharmaceutical Production Through Cyprus CCollaboration. Botswana is taking decisive steps toward positioning itself as a future producer of pharmaceutical commodities, a move that could reshape the country’s healthcare and business landscape.

Acting Minister of Health, Mr. Lawrence Ookeditse, announced at a press briefing on Friday that the ministry is actively exploring avenues for cooperation and investment in local pharmaceutical production, with Cyprus identified as a key partner in this effort.

“Botswana must not only remain consumers but also grow into producers in the pharmaceutical commodities space. This is how we build a sustainable health system—by developing our own capacity to meet our needs,” he stated.

The recent engagement with a Cypriot delegation is seen as a stepping stone toward building capacity and creating a robust pharmaceutical value chain in Botswana. Mr. Ookeditse noted that local production could strengthen supply chain resilience while unlocking economic opportunities through job creation, technology transfer, and increased investment in health infrastructure.

Priority areas include pediatrics and oncology, where the demand for consistent access to essential medicines continues to grow. By fostering partnerships, Botswana aims to secure long-term solutions that benefit both healthcare delivery and local industry development.

Cyprus High Commissioner to Botswana, Mr. Antonis Mandritis, reaffirmed his country’s commitment to supporting Botswana’s ambitions, emphasizing the importance of joint ventures, knowledge exchange, and advancing healthcare technology.

For Botswana’s entrepreneurs and investors, this development signals potential opportunities in pharmaceuticals, logistics, and healthcare services. The initiative aligns with the broader national goal of diversifying the economy while positioning Botswana as a hub for pharmaceutical manufacturing in Southern Africa.